Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seagen Inc. (SGEN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seagen Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1060736.
Total stock buying since 2014: $1,160,479,679.
Total stock sales since 2014: $1,004,689,522.
Total stock option exercises since 2014: $71,753,696.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 0 | $0 | 392,914 | $73,193,732 | 322,898 | $16,265,420 |
2022 | 0 | $0 | 250,716 | $37,014,358 | 234,844 | $7,144,665 |
2021 | 0 | $0 | 968,655 | $156,502,918 | 465,023 | $11,080,930 |
2020 | 0 | $0 | 3,776,313 | $607,190,520 | 685,142 | $14,851,091 |
2019 | 0 | $0 | 532,740 | $44,228,990 | 430,833 | $6,089,430 |
2018 | 5,306,804 | $275,895,222 | 375,703 | $24,277,576 | 373,126 | $4,469,898 |
2017 | 0 | $0 | 425,707 | $24,086,518 | 375,862 | $4,731,181 |
2016 | 6,200,638 | $257,974,072 | 373,779 | $18,628,401 | 407,265 | $4,207,373 |
2015 | 9,422,008 | $389,855,263 | 381,027 | $15,900,526 | 277,285 | $2,245,552 |
2014 | 7,019,620 | $236,755,122 | 89,351 | $3,665,983 | 86,333 | $668,156 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-03-09 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2020-03-06 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 115.31 | 922,504 |
2020-03-06 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,000 | 13.73 | 109,840 |
2020-02-18 | Dansey Roger D (Chief Medical Officer) | Sale | 350 | 116.33 | 40,715 |
2020-02-10 | Siegall Clay B (President and CEO) | Sale | 28,472 | 114.86 | 3,270,208 |
2020-02-10 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2020-02-03 | Dansey Roger D (Chief Medical Officer) | Sale | 727 | 108.51 | 78,886 |
2020-01-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 111.69 | 3,179,895 |
2020-01-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2020-01-07 | Welch Daniel G (Director) | Option Ex | 17,500 | 12.76 | 223,300 |
2019-12-16 | Dansey Roger D (Chief Medical Officer) | Sale | 2,000 | 114.07 | 228,140 |
2019-12-09 | Siegall Clay B (President and CEO) | Sale | 28,472 | 115.79 | 3,296,715 |
2019-12-09 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2019-12-06 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 117.35 | 938,800 |
2019-12-06 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,000 | 12.00 | 96,000 |
2019-11-25 | Dansey Roger D (Chief Medical Officer) | Sale | 5,000 | 121.48 | 607,390 |
2019-11-25 | Dansey Roger D (Chief Medical Officer) | Option Ex | 5,000 | 65.11 | 325,550 |
2019-11-21 | Akkaraju Srinivas (Director) | Sale | 17,500 | 119.98 | 2,099,737 |
2019-11-21 | Akkaraju Srinivas (Director) | Option Ex | 17,500 | 19.02 | 332,850 |
2019-11-18 | Dansey Roger D (Chief Medical Officer) | Sale | 5,000 | 116.00 | 580,000 |
2019-11-18 | Dansey Roger D (Chief Medical Officer) | Option Ex | 5,000 | 65.11 | 325,550 |
2019-11-18 | Lippman Marc E (Director) | Sale | 35,000 | 115.80 | 4,053,000 |
2019-11-18 | Lippman Marc E (Director) | Option Ex | 35,000 | 15.89 | 556,150 |
2019-11-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 106.43 | 3,030,218 |
2019-11-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2019-10-08 | Siegall Clay B (President and CEO) | Sale | 28,472 | 82.93 | 2,361,268 |
2019-10-08 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2019-10-01 | Gryska David W (Director) | Sale | 5,000 | 85.09 | 425,450 |
2019-10-01 | Gryska David W (Director) | Option Ex | 5,000 | 15.89 | 79,450 |
2019-09-30 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 7,432 | 86.00 | 639,152 |
2019-09-30 | Simpson Todd E (Chief Financial Officer) | Sale | 15,000 | 85.00 | 1,275,000 |
2019-09-25 | Dansey Roger D (Chief Medical Officer) | Sale | 3,000 | 73.98 | 221,940 |
2019-09-09 | Siegall Clay B (President and CEO) | Sale | 28,472 | 69.41 | 1,976,184 |
2019-09-09 | Siegall Clay B (President and CEO) | Option Ex | 28,472 | 12.00 | 341,664 |
2019-09-03 | Dansey Roger D (See Remarks) | Sale | 922 | 70.80 | 65,277 |
2019-09-03 | Himes Vaughn B (See Remarks) | Sale | 5,692 | 70.80 | 402,987 |
2019-09-03 | Liu Jean I (See Remarks) | Sale | 1,779 | .00 | 0 |
2019-09-03 | Simpson Todd E (See Remarks) | Sale | 2,092 | 70.80 | 148,111 |
2019-09-03 | Siegall Clay B (See Remarks) | Sale | 9,693 | 70.80 | 686,254 |
2019-08-30 | Himes Vaughn B (See Remarks) | Sale | 8,000 | 73.03 | 584,240 |
2019-08-30 | Himes Vaughn B (See Remarks) | Option Ex | 8,000 | 12.00 | 96,000 |
2019-08-28 | Himes Vaughn B (Chief Technical Officer) | Sale | 6,836 | 73.22 | 500,497 |
2019-08-28 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 6,013 | 73.22 | 440,241 |
2019-08-28 | Simpson Todd E (Chief Financial Officer) | Sale | 5,909 | 73.21 | 432,621 |
2019-08-28 | Siegall Clay B (President and CEO) | Sale | 28,951 | 73.22 | 2,119,647 |
2019-08-20 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 3,716 | 80.00 | 297,280 |
2019-08-20 | Simpson Todd E (Chief Financial Officer) | Sale | 12,500 | 80.00 | 1,000,000 |
2019-08-08 | Siegall Clay B (President and CEO) | Sale | 20,149 | 76.19 | 1,535,152 |
2019-08-08 | Siegall Clay B (President and CEO) | Option Ex | 20,149 | 12.16 | 245,011 |
2019-08-06 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 3,716 | 75.00 | 278,700 |
2019-07-17 | Gryska David W (Director) | Sale | 5,000 | 75.00 | 375,000 |
2019-07-17 | Gryska David W (Director) | Option Ex | 5,000 | 12.76 | 63,800 |
2019-07-08 | Siegall Clay B (President and CEO) | Sale | 20,148 | 67.50 | 1,359,929 |
2019-07-08 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2019-06-24 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 4,704 | 42.56 | 200,225 |
2019-06-17 | Dansey Roger D (Chief Medical Officer) | Sale | 5,416 | 68.60 | 371,537 |
2019-06-10 | Siegall Clay B (President and CEO) | Sale | 20,148 | 69.56 | 1,401,394 |
2019-06-10 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2019-05-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 66.08 | 528,680 |
2019-05-31 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,000 | 12.00 | 96,000 |
2019-05-09 | Siegall Clay B (President and CEO) | Sale | 4,824 | 67.35 | 324,896 |
2019-05-09 | Siegall Clay B (President and CEO) | Option Ex | 4,824 | 12.16 | 58,659 |
2019-05-08 | Siegall Clay B (President and CEO) | Sale | 15,324 | 68.22 | 1,045,449 |
2019-05-08 | Siegall Clay B (President and CEO) | Option Ex | 15,324 | 12.16 | 186,339 |
2019-04-29 | Baker Julian (Director) | Option Ex | 20,000 | 8.38 | 167,600 |
2019-04-08 | Siegall Clay B (President and CEO) | Sale | 20,148 | 78.94 | 1,590,483 |
2019-04-08 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2019-04-05 | Simpson Todd E (Chief Financial Officer) | Sale | 12,500 | 78.00 | 975,000 |
2019-04-01 | Gryska David W (Director) | Sale | 5,000 | 73.69 | 368,474 |
2019-04-01 | Gryska David W (Director) | Option Ex | 5,000 | 12.76 | 63,800 |
2019-03-18 | Siegall Clay B (President and CEO) | Option Ex | 16,556 | 12.08 | 199,996 |
2019-03-08 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,000 | 68.77 | 550,120 |
2019-03-08 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,000 | 12.00 | 96,000 |
2019-03-08 | Siegall Clay B (President and CEO) | Sale | 20,148 | 69.12 | 1,392,730 |
2019-03-08 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2019-03-04 | Simpson Todd E (Chief Financial Officer) | Sale | 10,000 | 75.00 | 750,000 |
2019-02-08 | Siegall Clay B (See Remarks) | Sale | 20,148 | 65.72 | 1,324,187 |
2019-02-08 | Siegall Clay B (See Remarks) | Option Ex | 20,148 | 12.16 | 244,999 |
2019-01-08 | Gryska David W (Director) | Sale | 5,000 | 65.04 | 325,200 |
2019-01-08 | Gryska David W (Director) | Option Ex | 5,000 | 12.76 | 63,800 |
2019-01-08 | Siegall Clay B (President and CEO) | Sale | 20,148 | 65.61 | 1,321,910 |
2019-01-08 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2018-12-10 | Siegall Clay B (President and CEO) | Sale | 20,148 | 59.96 | 1,208,134 |
2018-12-10 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2018-11-30 | Himes Vaughn B (Chief Technical Officer) | Sale | 5,000 | 62.42 | 312,125 |
2018-11-30 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 5,000 | 12.00 | 60,000 |
2018-11-29 | Cline Darren S (EVP, Commercial) | Sale | 7,000 | 62.88 | 440,160 |
2018-11-21 | Cline Darren S (EVP, Commercial) | Sale | 4,167 | 56.69 | 236,206 |
2018-11-08 | Siegall Clay B (President and CEO) | Sale | 20,148 | 61.66 | 1,242,426 |
2018-11-08 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2018-10-30 | Akkaraju Srinivas (Director) | Option Ex | 5,000 | 8.38 | 41,900 |
2018-10-08 | Siegall Clay B (President and CEO) | Sale | 20,148 | 77.27 | 1,556,835 |
2018-10-08 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2018-09-17 | Siegall Clay B (President and CEO) | Sale | 20,148 | 77.19 | 1,555,163 |
2018-09-17 | Siegall Clay B (President and CEO) | Option Ex | 20,148 | 12.16 | 244,999 |
2018-09-07 | Himes Vaughn B (Chief Technical Officer) | Sale | 5,000 | 76.73 | 383,675 |
2018-09-07 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 5,000 | 12.00 | 60,000 |
2018-08-27 | Cline Darren S (EVP, Commercial) | Sale | 4,784 | 74.23 | 355,125 |
2018-08-27 | Himes Vaughn B (Chief Technical Officer) | Sale | 5,530 | 74.23 | 410,502 |
2018-08-27 | Liu Jean I (GC/EVP, Leg Affairs) | Sale | 4,123 | 74.23 | 306,058 |
2018-08-27 | Simpson Todd E (Chief Financial Officer) | Sale | 5,427 | 74.23 | 402,857 |
2018-08-27 | Siegall Clay B (President and CEO) | Sale | 25,514 | 74.23 | 1,893,955 |
2018-08-21 | Siegall Clay B (President and CEO) | Sale | 25,000 | 74.95 | 1,873,750 |
2018-08-09 | Siegall Clay B (See Remarks) | Sale | 18,831 | 72.91 | 1,372,874 |
2018-08-09 | Siegall Clay B (See Remarks) | Option Ex | 18,831 | 11.09 | 208,835 |
2018-07-31 | Lippman Marc E (Director) | Sale | 7,400 | 69.25 | 512,450 |
2018-07-09 | Siegall Clay B (President and CEO) | Sale | 18,832 | 69.30 | 1,305,057 |
2018-07-09 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2018-06-12 | Cline Darren S (EVP, Commercial) | Sale | 12,054 | 68.99 | 831,581 |
2018-06-12 | Cline Darren S (EVP, Commercial) | Option Ex | 10,086 | 22.34 | 225,270 |
2018-06-08 | Siegall Clay B (President and CEO) | Sale | 18,832 | 65.37 | 1,231,047 |
2018-06-08 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2018-05-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 5,000 | 58.41 | 292,050 |
2018-05-31 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 5,000 | 12.00 | 60,000 |
2018-05-09 | Cline Darren S (EVP, Commercial) | Sale | 9,000 | 55.33 | 497,979 |
2018-05-09 | Cline Darren S (EVP, Commercial) | Option Ex | 9,000 | 15.94 | 143,415 |
2018-05-09 | Siegall Clay B (President and CEO) | Sale | 18,832 | 55.05 | 1,036,645 |
2018-05-09 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2018-05-08 | Baker Julian (Director) | Buy | 126,399 | 54.02 | 6,828,326 |
2018-05-07 | Baker Julian (Director) | Buy | 129,715 | 53.70 | 6,966,344 |
2018-05-04 | Baker Julian (Director) | Buy | 204,537 | 52.68 | 10,775,622 |
2018-05-03 | Cline Darren S (EVP, Commercial) | Sale | 4,000 | 53.81 | 215,240 |
2018-05-02 | Baker Julian (Director) | Buy | 69,947 | 52.72 | 3,687,605 |
2018-05-01 | Baker Julian (Director) | Buy | 306,917 | 51.54 | 15,819,422 |
2018-05-01 | Baker Julian (Director) | Option Ex | 20,000 | 10.08 | 201,600 |
2018-04-30 | Baker Julian (Director) | Buy | 623,136 | 51.06 | 31,817,947 |
2018-04-09 | Siegall Clay B (President and CEO) | Sale | 18,832 | 50.52 | 951,392 |
2018-04-09 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2018-03-20 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 31,039 | 16.04 | 497,958 |
2018-03-15 | Himes Vaughn B (See Remarks) | Sale | 5,000 | 58.48 | 292,375 |
2018-03-15 | Himes Vaughn B (See Remarks) | Option Ex | 5,000 | 12.00 | 60,000 |
2018-03-09 | Siegall Clay B (President and CEO) | Sale | 18,832 | 57.47 | 1,082,180 |
2018-03-09 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2018-03-05 | Drachman Jonathan G (CMO & EVP, R & D) | Sale | 10,457 | 52.91 | 553,279 |
2018-03-05 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 10,457 | 8.96 | 93,694 |
2018-02-13 | Welch Daniel G (Director) | Option Ex | 16,881 | 9.23 | 155,811 |
2018-02-09 | Siegall Clay B (President and CEO) | Sale | 18,832 | 50.18 | 944,933 |
2018-02-09 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2018-02-01 | Baker Felix (Director) | Buy | 3,846,153 | 52.00 | 199,999,956 |
2018-01-11 | Drachman Jonathan G (CMO & EVP, R & D) | Option Ex | 19,416 | 11.30 | 219,497 |
2018-01-11 | Siegall Clay B (President and CEO) | Sale | 18,832 | 52.12 | 981,523 |
2018-01-11 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2017-12-11 | Siegall Clay B (President and CEO) | Sale | 18,832 | 55.06 | 1,036,946 |
2017-12-11 | Siegall Clay B (President and CEO) | Option Ex | 18,832 | 11.09 | 208,846 |
2017-12-04 | Dobmeier Eric (Chief Operating Officer) | Sale | 3,729 | 58.75 | 219,093 |
2017-12-04 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 6,165 | 33.57 | 206,959 |
2017-11-30 | Himes Vaughn B (Chief Technical Officer) | Sale | 10,000 | 60.19 | 601,870 |
2017-11-30 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 10,000 | 12.11 | 121,070 |
2017-11-17 | Dobmeier Eric (Chief Operating Officer) | Sale | 10,000 | 59.12 | 591,250 |
2017-11-17 | Dobmeier Eric (Chief Operating Officer) | Option Ex | 10,000 | 26.10 | 261,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seagen Inc. (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.